| Value | ₹0.02 Cr |
|---|
NSE filing, NSE: EUREKAFORB. Summary written from the filing by ALFA Finder's alert engine.
Eureka Forbes Ltd: key numbers
- Share price
- ₹321.35
- Market cap
- ₹6,223 Cr
- Revenue (annual)
- ₹2,709 Cr
- Net profit (annual)
- ₹162.6 Cr
- P/E (TTM)
- 34.4×Sector 42.1×
- Promoter holding
- 62.51%-0.04% QoQ
- FII holding
- 13.22%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Eureka Forbes Ltd
All →Eureka Forbes Board Meeting Date
Eureka Forbes scheduled a board meeting for November 2, 2026 to approve Q2 and H1 FY27 results. Trading window stays closed until 48 hours after results publish.
Eureka Forbes Other Announcement
Eureka Forbes Ltd filed its quarterly shareholding pattern under Regulation 31(1)(b) for the quarter ended September 30, 2026. This is a routine regulatory compliance disclosure.
Eureka Forbes Employee Stock Options
Eureka Forbes Limited has allotted equity shares under its Employee Stock Option Plan (ESOP). This increases the company's paid-up share capital by 25,000 shares.
Eureka Forbes Employee Stock Options
Eureka Forbes allotted equity shares under its ESOP scheme, increasing the paid-up share capital by Rs. 0.025 Crore. This is an ESOP allotment.
- Value
- ₹0.03 Cr
Eureka Forbes Employee Stock Options
Eureka Forbes allotted 25,000 equity shares under its ESOP 2022 scheme at an exercise price of Rs. 210 per share, totaling Rs. 0.53 Crore.
- Value
- ₹0.53 Cr
Eureka Forbes Legal & Regulatory
Eureka Forbes received a rectified GST order from UP authorities, reducing the alleged liability from ₹273.40 Crore to ₹4.50 Crore. The company intends to contest this claim.
- Value
- ₹4.50 Cr
Other employee stock options announcements
All →Aye Finance Employee Stock Options
Aye Finance's employee welfare trust transferred 89,501 equity shares to grantees on exercising ESOP options. The share capital remains unchanged, so no new issuance occurs.
Aarti Pharmalabs Employee Stock Options
Aarti Pharmalabs granted 850 stock options to employees under its PSOP 2023 at Rs.5 exercise price. This is an employee incentive grant, not a capital raise.
OnEMI Technology Solutions Employee Stock Options
OnEMI Technology allotted 69,000 equity shares on exercise of employee stock options under the Kissht ESOP 2022 plan. The shares rank pari passu with existing equity.
Bliss GVS Pharma Employee Stock Options
Bliss GVS Pharma seeks shareholder approval via postal ballot for new employee stock option plans 2026. Up to 26,50,000 options are proposed; voting closes November 27, 2026.
Bandhan Bank Employee Stock Options
Bandhan Bank's board granted 32,98,871 stock options under ESOP Series 1 (Tranche 9) at Rs 151.91 per option. The options vest over four years, with each option convertible into one equity share.
Maxvolt Energy Industries Employee Stock Options
Maxvolt Energy granted 5,01,726 ESOPs to six employees under its MEIL ESOP 2025 scheme at exercise prices of ₹30 and ₹45. Options vest over four years, with exercise windows following vesting.
- Execution
- Vesting over 4 years from grant (25% at 2nd, 25% at 3rd, 50% at 4th anniversary); exercise over 3 years from each vesting date